Parkinsons Disease With Dementia (PDD) Completed Phase 2 Trials for Nelotanserin (DB12555)

Also known as: Dementia Parkinson's Disease / Parkinson Disease Dementia / Parkinson Disease-Dementia / Parkinson's Disease Dementia / Parkinson Disease Dementia (PDD) / Parkinson's Disease Dementia (PDD) / Parkinson's Disease With Dementia / Parkinsons Disease With Dementia / Dementia With Parkinson's Disease / Parkinson Disease With Dementia

IndicationStatusPhase
DBCOND0122035 (Parkinsons Disease With Dementia (PDD))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02708186Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)Treatment